|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 335.50 EUR | +0.30% |
|
+2.91% | -6.15% |
| 07-21 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 | ![]() |
| 07-21 | Despite the escalation in the Middle East, European stocks stay the course |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 412 | +23.17% | 8 | |||||||
| 113.82 | +52.64% | 17 | |||||||
| 30.07 | +21.35% | 14 | |||||||
| 17.35 | +108.53% | 2 | |||||||
| 3.256 | +8.13% | 6 | |||||||
| 14.42 | +24.74% | 4 | |||||||
| - | 45.6 | +33.96% | 5 | ||||||
| 20.41 | +26.93% | 3 | |||||||
| 9 | +39.1% | 2 | |||||||
| 90.38 | +27.65% | 4 | |||||||
| 18.5 | +46.25% | 2 | |||||||
| 14.75 | +43.76% | 2 | |||||||
| 39.5 | +82.87% | 2 | |||||||
| - | - | - | 3.36 | +0.75% | 1 | ||||
| Average | 59.46 | +38.56% | 5 | ||||||
| Weighted average by Cap. | 91.58 | +44.27% | 13 |
- Stock Market
- Stocks
- VIRP Stock
- Sector Virbac
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions

















